- Home
- PCRX vs NPKI Comparison
PCRX vs NPKI Comparison
Compare PCRX & NPKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- NPKI
- Stock Information
- Founded
- PCRX 2006
- NPKI 1932
- Country
- PCRX United States
- NPKI United States
- Employees
- PCRX N/A
- NPKI N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- NPKI Metal Fabrications
- Sector
- PCRX Health Care
- NPKI Industrials
- Exchange
- PCRX Nasdaq
- NPKI Nasdaq
- Market Cap
- PCRX 1.2B
- NPKI 722.7M
- IPO Year
- PCRX 2011
- NPKI N/A
- Fundamental
- Price
- PCRX $22.90
- NPKI $8.55
- Analyst Decision
- PCRX Buy
- NPKI Strong Buy
- Analyst Count
- PCRX 8
- NPKI 1
- Target Price
- PCRX $28.38
- NPKI $12.00
- AVG Volume (30 Days)
- PCRX 545.0K
- NPKI 790.3K
- Earning Date
- PCRX 07-29-2025
- NPKI 08-04-2025
- Dividend Yield
- PCRX N/A
- NPKI N/A
- EPS Growth
- PCRX N/A
- NPKI N/A
- EPS
- PCRX N/A
- NPKI N/A
- Revenue
- PCRX $702,772,000.00
- NPKI $233,299,000.00
- Revenue This Year
- PCRX $7.54
- NPKI $15.28
- Revenue Next Year
- PCRX $10.78
- NPKI $9.62
- P/E Ratio
- PCRX N/A
- NPKI $17.71
- Revenue Growth
- PCRX 3.08
- NPKI 312.30
- 52 Week Low
- PCRX $11.16
- NPKI $4.76
- 52 Week High
- PCRX $27.64
- NPKI $8.88
- Technical
- Relative Strength Index (RSI)
- PCRX 35.82
- NPKI N/A
- Support Level
- PCRX $22.82
- NPKI N/A
- Resistance Level
- PCRX $23.83
- NPKI N/A
- Average True Range (ATR)
- PCRX 0.74
- NPKI 0.00
- MACD
- PCRX -0.02
- NPKI 0.00
- Stochastic Oscillator
- PCRX 6.22
- NPKI 0.00
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About NPKI NPK International Inc. Common Stock
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.